MENU
ACIU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AC Immune SA (ACIU) Earnings Date & Reports

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases... Show more

A.I. Advisor
published Earnings

ACIU is expected to report earnings to rise 27.58% to -20 cents per share on April 24

AC Immune SA ACIU Stock Earnings Reports
Q1'25
Est.
$-0.21
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.19
Q2'24
Missed
by $0.71
Q1'24
Missed
by $0.08
The last earnings report on March 13 showed earnings per share of -16 cents, beating the estimate of -18 cents. With 57.29K shares outstanding, the current market capitalization sits at 188.77M.
View a ticker or compare two or three
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com